Omnicell Inc (OMCL)
Industry Health Information Services
This stock can be held in an Investment ISA and an Investment Account
Sell
$43.02
Buy
$45.00
$0.57 (+1.32%)
Prices updated at 13 Dec 2025, 00:38 EST
| Prices minimum 15 mins delay
Prices in USD
Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 42.35 |
| 2023 | 43.31 |
| 2022 | 45.45 |
| 2021 | 49.00 |
| 2020 | 46.32 |
| 2019 | 48.71 |
| 2018 | 47.29 |
| 2017 | 44.71 |
| 2016 | 45.56 |
| 2015 | 51.17 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 1.74 |
| 2024 | 1.92 |
| 2023 | 1.43 |
| 2022 | 1.83 |
| 2021 | 7.82 |
| 2020 | 5.87 |
| 2019 | 4.03 |
| 2018 | 3.23 |
| 2017 | 2.62 |
| 2016 | 1.91 |
| 2015 | 2.40 |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | 0.58 |
| 2023 | -0.92 |
| 2022 | 0.26 |
| 2021 | 3.92 |
| 2020 | 2.10 |
| 2019 | 5.28 |
| 2018 | 3.60 |
| 2017 | 3.13 |
| 2016 | 1.29 |
| 2015 | 5.40 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.71 |
| 2023 | 1.87 |
| 2022 | 1.96 |
| 2021 | 1.87 |
| 2020 | 1.89 |
| 2019 | 1.47 |
| 2018 | 1.59 |
| 2017 | 1.83 |
| 2016 | 2.17 |
| 2015 | 1.44 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
